Structural Elucidations of NMR spectra, whether combined with other analytical techniques, or on their own, are akin to the challenges of the most complex cryptic crosswords—maybe the kind you find in the weekend editions of The Guardian, or The Times—but much, much tougher with some clues sometimes missing. At least that’s why I believe some of our internal experts and application scientists like the challenges of solving these “puzzles” on a regular basis.
At times, it seems that our world is revolving faster and faster, with the industry and economy speeding up through a colossal pace of change. Let me sincerely wish you and your loved ones this holiday season, and at the eve of the New Year, inner peace and stability, in this moment and in every moment of 2017.
With the help of ACD/Labs’ software, PharmaSea researchers have dereplicated more than 300 extracts, and, as a result, have identified 10 novel compounds that merit further research. Prof. Marcel Jaspars, head of the Marine Biodiscovery Centre at the University of Aberdeen, and project leader of PharmaSea, discusses the PharmaSea project in detail here.
I speak for our organization when I say the entire ACD/Labs team feels continuously connected to the successes of our customers. Like most of you, members of our team have dedicated years to the advancement of chemistry R&D, which has led to many business relationships, and more importantly, personal friendships. It’s not only our business, it’s our passion. On behalf of all of us at ACD/Labs, I would like to wish you a successful year ahead!
Welcome to our company blog! We’re excited to announce the launch of this entirely new resource created specifically for our loyal ACD/Labs followers. Our posts will appear every few weeks, and they will include new thought provoking content, exclusive company news, and (most importantly) fun and entertaining updates from the ACD/Labs team. Considering today is our first post, we thought we’d start off with some good news! We’d like to take this opportunity to introduce Andrew Anderson, our new VP of Business Development. Andrew joins ACD/Labs from PepsiCo, Symyx before that, and…well… ACD/Labs.